[go: up one dir, main page]

AU2003261756A1 - Acrylamide derivatives - Google Patents

Acrylamide derivatives

Info

Publication number
AU2003261756A1
AU2003261756A1 AU2003261756A AU2003261756A AU2003261756A1 AU 2003261756 A1 AU2003261756 A1 AU 2003261756A1 AU 2003261756 A AU2003261756 A AU 2003261756A AU 2003261756 A AU2003261756 A AU 2003261756A AU 2003261756 A1 AU2003261756 A1 AU 2003261756A1
Authority
AU
Australia
Prior art keywords
acrylamide derivatives
acrylamide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003261756A
Other languages
English (en)
Inventor
Miyuki Funahashi
Takayuki Imaoka
Masanobu Kaneeda
Masayuki Kaneko
Hirokazu Kubota
Koichiro Morihira
Tatsuaki Morokata
Ippei Sato
Masaki Yokota
Kazuhiro Yokoyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Toray Industries Inc
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2002248660A external-priority patent/JP2004083511A/ja
Priority claimed from JP2003091009A external-priority patent/JP2006076884A/ja
Application filed by Toray Industries Inc, Yamanouchi Pharmaceutical Co Ltd filed Critical Toray Industries Inc
Publication of AU2003261756A1 publication Critical patent/AU2003261756A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003261756A 2002-08-28 2003-08-27 Acrylamide derivatives Abandoned AU2003261756A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002248660A JP2004083511A (ja) 2002-08-28 2002-08-28 アクリルアミド誘導体
JP2002-248660 2002-08-28
JP2003091009A JP2006076884A (ja) 2003-03-28 2003-03-28 アクリルアミド誘導体
JP2003-91009 2003-03-28
PCT/JP2003/010845 WO2004022535A1 (fr) 2002-08-28 2003-08-27 Derives d'acrylamide

Publications (1)

Publication Number Publication Date
AU2003261756A1 true AU2003261756A1 (en) 2004-03-29

Family

ID=31980498

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003261756A Abandoned AU2003261756A1 (en) 2002-08-28 2003-08-27 Acrylamide derivatives

Country Status (2)

Country Link
AU (1) AU2003261756A1 (fr)
WO (1) WO2004022535A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12054479B1 (en) 2022-03-14 2024-08-06 Slap Pharmaceuticals Llc Multicyclic compounds

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004023507A1 (de) * 2004-05-10 2005-12-01 Grünenthal GmbH Substituierte Cyclohexylessigsäure-Derivate
PT1877379E (pt) * 2005-04-13 2013-04-17 Astex Therapeutics Ltd Derivados de hidroxibenzamida e seu uso como inibidores de hsp90
US7700593B2 (en) * 2006-10-11 2010-04-20 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use thereof
AU2008209749A1 (en) * 2007-01-31 2008-08-07 Novartis Ag Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
ES2422603T3 (es) 2007-05-31 2013-09-12 Shionogi & Co Compuestos oxiimino y el uso de estos
ES2408159T3 (es) 2008-06-11 2013-06-18 Shionogi & Co., Ltd. Compuestos de oxicarbamoilo y su utilización
CA2757726A1 (fr) * 2009-04-02 2010-10-07 Shionogi & Co., Ltd. Composes acrylamides et leur utilisation
KR20240035395A (ko) 2021-06-14 2024-03-15 스코르피온 테라퓨틱스, 인코퍼레이티드 암 치료에 사용할 수 있는 요소 유도체
UY40356A (es) * 2022-07-18 2024-01-31 Pi Industries Ltd Un proceso para la síntesis de ácidos 4-alcoxi-3-hidroxipicolínicos e intermedios de los mismos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1171350A (ja) * 1997-06-17 1999-03-16 Takeda Chem Ind Ltd ヒドロキシピペリジン化合物およびその剤
AU2001280187A1 (en) * 2000-08-28 2002-03-13 Toray Industries, Inc. Cyclic amine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12054479B1 (en) 2022-03-14 2024-08-06 Slap Pharmaceuticals Llc Multicyclic compounds

Also Published As

Publication number Publication date
WO2004022535A1 (fr) 2004-03-18

Similar Documents

Publication Publication Date Title
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
EP1682493B8 (fr) Derives d'amidoacetonitrile
AU2003281040A1 (en) Biaryl derivatives
AU2003220935A1 (en) Benzamide derivatives
PL374718A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (fr) Derives d'azaarene
AU2003211362A1 (en) N-hydroxycarboxamide derivative
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
EP1606277B8 (fr) Derives de l'imidazol-4-yl-ethynyl-pyridine
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
EP1706373B8 (fr) Derives d'amidoacetonitrile
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003261756A1 (en) Acrylamide derivatives
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003231370A1 (en) Amide derivatives
AU2003235889A1 (en) Amide derivatives
EP1531854A4 (fr) Derives de nocathiacine o-derivatises
AU2003273398A1 (en) Aroyl-piperidine derivatives
AU2003238180A1 (en) 2-naphtamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase